Similar Papers

Paper Title
Journal
Date
Author
COVID-19 Vaccination in Adults with Immune Thrombocytopenia (ITP): Data from the Platelet Disorder Support Association (PDSA) Patient Registry
Jennifer Macwhirter - Diraimo ... Alexandra Kruse
Blood | VOL. 138
Jennifer Macwhirter - Diraimo, et. al.Jennifer Macwhirter - Diraimo ... Alexandra Kruse
05 Nov 2021
Mental Health and Treatment in Patients with Immune Thrombocytopenia (ITP); Data from the Platelet Disorder Support Association (PDSA) Patient Registry
Alexandra Kruse ... James B Bussel
Blood | VOL. 134
Alexandra Kruse, et. al.Alexandra Kruse ... James B Bussel
13 Nov 2019
Sars-Cov-2 Vaccination in Patients with Pre-Existing Immune Thrombocytopenia
Eun-Ju Lee ... James B Bussel
Blood | VOL. 138
Eun-Ju Lee, et. al.Eun-Ju Lee ... James B Bussel
05 Nov 2021
COVID-19 Vaccination in Children and Young Adults with Pre-Existing Immune Thrombocytopenia (ITP): Preliminary Data from the Platelet Disorder Support Association (PDSA) Patient Registry
Jennifer Macwhirter - Diraimo ... James B Bussel
Blood | VOL. 140
Jennifer Macwhirter - Diraimo, et. al.Jennifer Macwhirter - Diraimo ... James B Bussel
15 Nov 2022
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Woyach JA, Burbano GP, Ruppert AS, etal. Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL. Blood. 2024;143(16):1616-1627.
-
Blood | VOL. 145
--
30 Jan 2025
A novel therapy with a rational design for AML.
Maria L Amaya
Blood | VOL. 145
Maria L AmayaMaria L Amaya
30 Jan 2025
For how long has this problem been there?
Niccolò Bolli ... Matteo Claudio Da Vià
Blood | VOL. 145
Niccolò Bolli, et. al.Niccolò Bolli ... Matteo Claudio Da Vià
30 Jan 2025
Targeting CD47: many misses; hopeful for a hit.
Lindsay Wilde ... Margaret Kasner
Blood | VOL. 145
Lindsay Wilde, et. al.Lindsay Wilde ... Margaret Kasner
30 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.